Amgen Stock - Weekly outlook with upcoming catalysts

Amgen stock enters the new week with a full pipeline of data readouts, regulatory milestones and the next earnings date on investors’ calendars. Here is what is lined up and how the biotech group is positioned in the wider pharma sector.

Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 10:41 CET. Details in the imprint.

Amgen (US0311621009) opens the new week with investors watching its pipeline milestones and the calendar for the next set of quarterly numbers. With no fresh company-specific headlines overnight from major wires, the focus turns to the coming earnings date and clinical updates.

What the week may bring

For Amgen, the next firm date on many calendars is the company’s second-quarter 2026 earnings release, which market data providers currently expect in late July, although an exact date has not yet been officially confirmed on the company’s website.

Sell-side models compiled by several financial portals point to modest top-line growth for 2026, driven by newer products offsetting erosion in mature brands, while investors will watch closely for any management commentary on margins and capital allocation.

Earnings and calendar focus

Amgen historically reports quarterly results roughly one month after the end of each quarter, and the company typically confirms the precise release date and conference call details through its investor relations page ahead of time.

Alongside the earnings date, the investor agenda over the coming weeks may include scientific congress presentations, potential regulatory decisions on pipeline assets and any updates on previously guided full-year revenue and earnings-per-share ranges.

The product behind the stock

Amgen generates revenue primarily from innovative biopharmaceuticals, including established therapies in oncology, hematology, inflammation, bone health and cardiovascular disease, complemented by biosimilars that broaden patient access to biologic treatments.

Where the stock trades today

Amgen shares (US0311621009) trade on Nasdaq at around $337 per share as of the most recent close, according to recent market data.

Key facts on Amgen stock

• Company: Amgen Inc.
• ISIN: US0311621009
• WKN: 867900
• Ticker: AMGN
• Venue: Nasdaq
• Price (as of 06/18/2026, 16:00 ET): 337.60 USD
• Market cap: 181,000,000,000 USD (as of 06/18/2026)
• Sector / Industry: Health Care / Biotechnology
• Index membership: Standard & Poor's 500 index, Nasdaq-100
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.